newsfilter
← Latest News
Business Wire·

Athersys Restructures Debt with Supplier

Athersys, Inc. (NASDAQ:ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications announced it has restructured its outstanding debt with a supplier